MORF Morphic Holding, Inc.

21.01-1.03 (-4.67%)
Close: August 23, 2019

22.041.03 (+4.90%)
Pre-market

Quote

Previous Close
$21.01
Day Range
$21.01-$22.62
52 Week Range
$15.72-$33.50
Volume
17,255
Avg Volume
62,360
Dividend TTM
-
Ex-Dividend Date
-

Valuation

Market Cap
$640.72M
Enterprise Value (EV)
$626.04M
PE Ratio
-
EV/EBITDA
-25.99
Price/Sales
-
Price/Book
-
PEG Ratio
-

Financials

Revenue
-
Gross Profit
-
EBITDA
-$24.09M
EPS, ttm
-
Profit Margin
-
Revenue/Employee
-
Next Earnings Date
11/27/2019 (94 days)
Debt to Equity
-266%
Debt
$171.22M
Cash
$185.90M
Net Debt
-

Performance

Beta
1.65
200 Day Moving Avg
$21.85
50 Day Moving Avg
$21.85
52 Week Change
16.72%
YTD Change
12.05%
1 Month Change
1.45%
3 Month Change
16.72%
6 Month Change
16.72%
1 Year Change
16.72%
2 Year Change
-
5 Year Change
-

Share Count

Shares Outstanding
30.5M
Float
10.7M
Restricted Shares
19.8M
Restricted Shares, %
64.78%

Morphic Holding, Inc. Company Details

Sector: Health Technology

Industry: Biotechnology

CEO: Praveen P. Tipirneni

Website: -

Description: Morphic Holding, Inc. operates as a biopharmaceutical company, which engages in the research and development of oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas. The company was founded by Timothy A. Springer in August 2014 and is headquartered in Waltham, MA.

Employees: 37